Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia
暂无分享,去创建一个
I. Láng | M. Bronchud | L. Mattano | C. Waller | G. Ranganna | A. Barve | I. Lytvyn | Rajiv Sharma | Y. Shparyk | K. Beckmann | Mark Baczkowski | E. Pennella | A. Rusyn | C. Blakeley | N. Voitko | V. Popov | M. Kothekar | O. Berzoy